Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells
2006 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.
1992
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
PARMA international protocol: Pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
1991
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Cell Proliferation in Carcinogenesis
1990 Science
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma
2007
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Exercise Standards for Testing and Training
2013 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
Interleukin-10 in Non-Hodgkin's Lymphoma
1997
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Immune Thrombocytopenic Purpura
2002 Standout
Graft-versus-host disease
2009 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?
2004
IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma
1999
Hematopoietic Stem-Cell Transplantation
2006 Standout
Molecular themes in oncogenesis
1991 StandoutNobel
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
2003 Standout
Activation-Induced Cytidine Deaminase Expression in CD4+ T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age
2011 StandoutNobel
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia
2004
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
The pathophysiology and management of thrombotic thrombocytopenic purpura
1996
Mismatch Repair Deficiency in Phenotypically Normal Human Cells
1995 StandoutScienceNobel
A review of autologous hematopoietic cell transplantation
2000 Nobel
Epidemiology and prevention of bladder cancer
2001
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial
1996
Alternative activation of macrophages
2003 Standout
A review of the association between interleukin-10 and human B-cell malignancies
1998
Cancer of the Ovary
2004 Standout
Re‐evaluation of the role of azathioprine in the treatment of adult chronic idiopathic thrombocytopenic purpura: a report on 53 cases
1990
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
2007
Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids
1985
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells
2004 StandoutNobel
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
Daunomycin-induced cardiotoxicity in children and adults
1977
Developmental neurobiology of childhood stress and trauma
2002
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
1986 StandoutScience
Correlation of two in vitro tests with clinical response to immunosuppressive therapy in 54 patients with severe aplastic anemia
1984
Patterns of gene expression and the cellular origins of human leukaemias
1978
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 StandoutScienceNobel
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
Anomalous phenotype in thymic acute lymphoblastic leukaemia
1980 StandoutNatureNobel
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
1992
Topical Instillation of Doxorubicin Hydrochloride in the Treatment of Recurring Superficial Transitional Cell Carcinoma of the Bladder
1977
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
1985 Standout
Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients
1997
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Clinical Significance of Circulating Proinsulin and C-Peptide
1977
Pericarditis in a Case of Early Daunorubicin Cardiomyopathy
1976
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1987
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
2008
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
2000
Autologous Stem Cell Transplantation in Acute Myelocytic Leukemia
1998
Chronic Myelogenous Leukemia — New Concepts
1981
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.
1974
“sternberg‐reed” giant cells of hodgkin's disease: Cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages
1977
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Antithymocyte Globulin Treatment in Patients with Aplastic Anemia
1983
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
1997
Staining of interleukin-10 predicts clinical outcome in patients with nasopharyngeal carcinoma
1999
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
1992 Standout
Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia
1978 Nobel
Inhibitors of human immunodeficiency virus integrase.
1993 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion
1984
Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
1991
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia
1983
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience
2000
MANAGEMENT OF CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA
1983
Effect of doxorubicin and rubidazone on respiratory function and Ca2+ transport in rat heart mitochondria
1979
Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response
2022 StandoutNobel
Parma international protocol: pilot study of DHAP followed by involved- field radiotherapy and BEAC with autologous bone marrow transplantation
1991
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Blast crisis of chronic granulocytic leukemia
1977
Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis.
2001
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
2000
Altered cerebral vasoregulation in hypertension and stroke
2003
Works of E Damasio being referenced
E2A–PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features
2003
Prognostic value of serum IL‐10 and soluble IL‐2 receptor levels in aggressive non‐Hodgkin's lymphoma
1994
Clinical implications of cytokine and soluble receptor measurements in patients with newly‐diagnosed aggressive non‐Hodgkin's lymphoma
1995
Idarubicin in combination with intermediate‐dose cytarabine in the treatment of refractory or relapsed acute leukemias*
1989
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission
1991
Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia
1987
Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma.Identification of a subset at high risk of treatment failure
1994
The Treatment of Terminal Metamorphosis of Chronic Granulocytic Leukaemia with Corticosteroids and Vincristine
1973
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
1991
Severe Aplastic Anaemia: Correlation of in Vitro Tests with Clinical Response to Immunosuppression in 20 Patients
1981
The Effects of Two Alkaloids Derived from Vinca Rosea on the Malignant Cells of Hodgkin’s Disease, Lymphosarcoma and Acute Leukemia in Vivo
1967
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
1996
CARDIAC TOXICITY OF DAUNORUBICIN
1969
Immunofluorescent Diagnosis of Acute Lymphoblastic Leukaemia
1975
Treatment of idiopathic thrombocytopenic purpura in HIV-positive patients with rhesus antibodies (anti-D).
1988
A to O Bone Marrow Transplantation in Severe Aplastic Anaemia: Dynamics of Blood Group Conversion and Demonstration of Early Dyserythropoiesis in the Engrafted Marrow
1977
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study
1985
Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus
1996
High-dose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy
1984
Clinical Experiences with Cytotoxic Immunosuppressive Treatment of Idiopathic Thrombocytopenic Purpura
1971
Thrombotic thrombocytopenic purpura successfully treated with a combination of dipyridamole and aspirin.
1980